Shuchi Nahar's Weekend Blog!

Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expansion – To

Syngene Q4FY21 and Full Year FY21 - Result Update  Twitter Handle: @shuchi_nahar Syngene International Limited on 28 th April 2021 announced its Q4FY21 and full-year results. The Company reported quarterly revenue from operations of Rs. 659 Cr and Rs. 2,184 Cr for the full year. Underlying revenue from operations (excluding export incentives) for the quarter grew 13% compared with the same period last year and by 12% for the full year. Profit after tax (before exceptional gain) for the quarter increased by 15% year-on-year to Rs. 138 Cr, and by 4% to Rs. 382 Cr for the full year. Revenue Growth over the Years 1. Growth driven by an increase in sales from existing clients and acquisition of new clients  2. Engage, expand and extend the strategy to extend client relationship over a longer period of time  3. Growth in the total number of clients  4. Increase in average revenue from largest clients  5. Increase in number of services offered to clients The highlight of the quarter was the

Enzymes – Improving every life, every day Twitter: shuchi_nahar The Indian enzyme market is yet to find its feet, as it is quite small when compared to the other sectors in the country. However, the growing awareness about the capabilities of enzymes and the subsequent benefits (both nutrition and cost-wise) will be important growth factors in the coming years. Nature’s enzymes and microbes are at work everywhere – from converting sugar into energy inside your cells, to enabling photosynthesis in the trees and plants outside your window.  What are Enzymes? Enzymes are proteins that act as catalysts. When one substance needs to be transformed into another, nature uses enzymes to speed up the process. In our stomachs, for example, enzymes break down food into tiny particles to be converted into energy. Enzymes are used as catalysts to manufacture a variety of everyday products - like sugar, beer, bread, and ethanol. They are also used directly in products such as laundry detergent, where

Companion Animal Healthcare Industry in India - Huge Opportunities Ahead Twitter Handle: @shuchi_nahar   Overview The global companion animal market size in 2019 was worth US$ 12.54 billion and expected to reach US$ 19.18 billion by 2024 with a growth rate at a CAGR of 6.26%. The Indian animal health market is currently witnessing strong growth and expected to achieve a CAGR of 5.5% between 2020 and 2025. The animal healthcare sector in India has witnessed a paradigm shift over the last few years because of the adoption of innovative technologies used for prevention and cure of farm and companion animals. Growing urbanization, changing lifestyle, and increase in per capita income have encouraged pet ownership as well as increased willingness to pay for pets, healthcare has supported the growth of Animal Healthcare. Scope Pets have evolved from being a strange and wonderful distraction to an integral part of families all over the world. As human populations have grown, so too ha